The human papillomavirus-16 e7 oncoprotein exerts antiapoptotic effects via its physical interaction with the actin-binding protein gelsolin

Carcinogenesis

Volumn 34, Issue 10, 2013, Pages 2424-2433

  Mileo, Anna M ^a   Abbruzzese, Claudia ^a   Vico, Carmen ^a   Bellacchio, Emanuele ^b   Matarrese, Paola ^c   Ascione, Barbara ^c   Federico, Antonio ^a   Bianca, Stefano Della ^a   Mattarocci, Stefano ^a   Malorni, Walter ^c,d   Paggi, Marco G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Istituto San Raffaele   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; GELSOLIN; PROTEIN E7;

ACTIN FILAMENT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE S PHASE; CELL IMMORTALIZATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ACTINS; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; GELSOLIN; HUMANS; MOLECULAR DOCKING SIMULATION; MUTATION; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING;

EID: 84885107546     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt192     Document Type: Article

References (47)

1. zur Hausen, H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer, 2, 342-350.
2. Münger, K. et al. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J. Virol., 78, 11451-11460.
3. D'Souza, G. et al. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med., 356, 1944-1956.
4. Pfister, H. (2003) Chapter 8: Human papillomavirus and skin cancer. J. Natl Cancer Inst. Monogr., 52-56. PMID: 12807946.
5. zur Hausen, H. (2009) The search for infectious causes of human cancers: where and why (Nobel lecture). Angew. Chem. Int. Ed. Engl., 48, 5798-5808.
6. De Flora, S. et al. (2011) The prevention of infection-associated cancers. Carcinogenesis, 32, 787-795.
7. Fehrmann, F. et al. (2003) Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene, 22, 5201-5207.
8. Whiteside, M.A. et al. (2008) Human papillomavirus and molecular considerations for cancer risk. Cancer, 113(suppl. 10), 2981-2994.
9. McLaughlin-Drubin, M.E. et al. (2009) The human papillomavirus E7 oncoprotein. Virology, 384, 335-344.
10. Münger, K. et al. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-7898.
11. Helt, A.M. et al. (2003) Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis, 24, 159-169.
12. Felsani, A. et al. (2006) Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene, 25, 5277-5285.
13. McGough, A.M. et al. (2003) The gelsolin family of actin regulatory proteins: modular structures, versatile functions. FEBS Lett., 552, 75-81.
14. Silacci, P. et al. (2004) Gelsolin superfamily proteins: key regulators of cellular functions. Cell. Mol. Life Sci., 61, 2614-2623.
15. Archer, S.K. et al. (2005) Evolution of the gelsolin family of actin-binding proteins as novel transcriptional coactivators. Bioessays, 27, 388-396.
16. Li, G.H. et al. (2012) Multifunctional roles of gelsolin in health and diseases. Med. Res. Rev., 32, 999-1025.
17. Kwiatkowski, D.J. et al. (1986) Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature, 323, 455-458.
18. Boccellino, M. et al. (2004) Apoptosis induced by interferon-alpha and antagonized by EGF is regulated by caspase-3-mediated cleavage of gelsolin in human epidermoid cancer cells. J. Cell. Physiol., 201, 71-83.
19. Kothakota, S. et al. (1997) Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science, 278, 294-298.
20. Koya, R.C. et al. (2000) Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem., 275, 15343-15349.
21. Kusano, H. et al. (2000) Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene, 19, 4807-4814.
22. Harms, C. et al. (2004) Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization. Mol. Cell. Neurosci., 25, 69-82.
23. Sakurai, N. et al. (2006) Posttranslational N-myristoylation is required for the anti-apoptotic activity of human tGelsolin, the C-terminal caspase cleavage product of human gelsolin. J. Biol. Chem., 281, 14288-14295.
24. Mileo, A.M. et al. (2006) Multiple interference of the human papillomavirus- 16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein. J. Bioenerg. Biomembr., 38, 215-225.
25. Severino, A. et al. (2007) Human papillomavirus-16 E7 interacts with Siva-1 and modulates apoptosis in HaCaT human immortalized keratinocytes. J. Cell. Physiol., 212, 118-125.
26. De Luca, A. et al. (2003) E1A deregulates the centrosome cycle in a Ran GTPase-dependent manner. Cancer Res., 63, 1430-1437.
27. Sali, A. et al. (1993) Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol., 234, 779-815.
28. Ritchie, D.W. et al. (2000) Protein docking using spherical polar Fourier correlations. Proteins, 39, 178-194.
29. Severino, A. et al. (2004) RACK1 is a functional target of the E1A oncoprotein. J. Cell. Physiol., 199, 134-139.
30. Harlow, E. et al. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
31. Patterson, R.L. et al. (1999) Store-operated Ca2+ entry: evidence for a secretion-like coupling model. Cell, 98, 487-499.
32. Mileo, A.M. et al. (2009) Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival. PLoS One, 4, e7254.
33. Sun, H.Q. et al. (1994) The actin side-binding domain of gelsolin also caps actin filaments. Implications for actin filament severing. J. Biol. Chem., 269, 9473-9479.
34. Way, M. et al. (1992) Evidence for functional homology in the F-actin binding domains of gelsolin and alpha-actinin: implications for the requirements of severing and capping. J. Cell Biol., 119, 835-842.
35. Lin, K.M. et al. (2000) Ca2+ regulation of gelsolin by its C-terminal tail. J. Biol. Chem., 275, 27746-27752.
36. Lueck, A. et al. (2000) Calcium regulation of gelsolin and adseverin: a natural test of the helix latch hypothesis. Biochemistry, 39, 5274-5279.
37. Nag, S. et al. (2009) Ca2+ binding by domain 2 plays a critical role in the activation and stabilization of gelsolin. Proc. Natl Acad. Sci. USA, 106, 13713-13718.
38. Li, G.H. et al. (2012) Multifunctional roles of gelsolin in health and diseases. Med. Res. Rev., 32, 999-1025.
39. Zwerschke, W. et al. (2000) Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv. Cancer Res., 78, 1-29.
40. dos Remedios, C.G. et al. (2003) Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol. Rev., 83, 433-473.
41. Tanaka, H. et al. (2006) siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells. Int. J. Cancer, 118, 1680-1691.
42. Hellner, K. et al. (2009) HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology, 391, 57-63.
43. Lee, M.Y. et al. (2012) Epithelial-mesenchymal transition in cervical carcinoma. Am. J. Transl. Res., 4, 1-13.
44. Auvinen, E. et al. (2013) Altered expression of ezrin, E-Cadherin and β-Catenin in cervical neoplasia. Neoplasma, 60, 56-61.
45. Craene, B.D. et al. (2012) Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer., 13, 97-110.
46. Lavia, P. et al. (2003) Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability. Oncogene, 22, 6508-6516.
47. Bellacchio, E. et al. (2013) Understanding the targeting of the RB family proteins by viral oncoproteins to defeat their oncogenic machinery. J. Cell. Physiol., 228, 285-291.